Status:
COMPLETED
Ex Vivo Human Thrombosis Chamber Study
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Cardiovascular Disease
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
Purpose of study is to evaluate a thrombosis chamber model
Eligibility Criteria
Inclusion
- Healthy Subjects
- BMI 18-30 kg/m²
- Male ages 18-45
Exclusion
- Significant acute or chronic illness
- History of abnormal bleeding or coagulation disorder, intracranial hemorrhage, or a family history of abnormal bleeding or coagulation disorder in a first degree relative under 50 years of age
- Easy bruising
- Smoking within 3 months prior to Day 1
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00935506
Start Date
July 1 2009
End Date
October 1 2009
Last Update
February 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mds Pharma Services
Neptune City, New Jersey, United States, 07753